The effect of in vitro gastrointestinal digestion on the release of microencapsulated phenolic compounds was evaluated through an optimized spray drying process. A stock extract of oregano phenolic compounds was developed and microencapsulated in a spray dryer following a central composite rotatable design, controlling the variables, inlet temperature (111.7-168.2°C), and percentage of wall material (5.8-34.1%). Optimum drying conditions for spray drying were decided based on different yield percentages ( %) and encapsulated phenolic compounds (EPC). The analyzed physical properties were morphology measured by electron microscopy and humidity; other properties evaluated were the content of total phenolic compounds, antioxidant capacity determined by DPPH and ABTS assays, and phenolic profile by ultraperformance liquid chromatography coupled to mass spectrometry (UPLC-MS). During the gastrointestinal simulation, a stability of 85% was determined in the intestinal stage. Microencapsulation technology by spray drying is an excellent selection to stabilize and protect bioactive compounds of oregano and promote its use as a functional ingredient.
Chitosan is a non-toxic, biodegradable, and biocompatible natural biopolymer widely used as a nanocarrier, emulsifier, flocculant, and antimicrobial agent with potential applications in industry. Recently, chitosan has been used as an encapsulating agent for bioactive plant compounds and agrochemicals by different technologies, such as spray-drying and nanoemulsions, to enhance antimicrobial activity. Chitosan nanocomposites have been shown to increase potential biocidal, antibacterial, and antifungal activity against pathogens, presenting higher stability, decreasing degradation, and prolonging the effective concentration of these bioactive compounds. Therefore, the objective of this work is to review the most outstanding aspects of the most recent developments in the different methods of encapsulation of bioactive compounds (phenolic compounds, essential oils, among others) from plants, as well as the applications on phytopathogenic diseases (fungi and bacteria) in vitro and in vivo in cereal, fruit and vegetable crops. These perspectives could provide information for the future formulation of products with high efficacy against phytopathogenic diseases as an alternative to chemical products for sustainable agriculture.
Mexican oregano (Lippia graveolens) is an important source of bioactive compounds, such as flavonoids. These have presented different therapeutic properties, including antioxidant and anti-inflammatory; however, their functionality is related to the quantity and type of compounds, and these characteristics depend on the extraction method used. This study aimed to compare different extraction procedures to identify and quantify flavonoids from oregano (Lippia graveolens). Emerging and conventional technologies include maceration with methanol and water, and ultrasound-assisted extraction (UAE) using deep eutectic solvents (DES) such as choline chloride-ethylene glycol, choline chloride-glycerol, and choline chloride-lactic acid. Supercritical fluid extraction using CO2 as a solvent was also studied. Six different extracts were obtained and the total reducing capacity, total flavonoid content, and antioxidant capacity by ABTS•+, DPPH•, FRAP, and ORAC were evaluated. In addition, flavonoids were identified and quantified by UPLC-TQS-MS/MS. Results showed that UAE-DES had the best extraction effect and antioxidant capacity using colorimetric methods. However, maceration-methanol was superior in compound content, and highlighting naringenin and phloridzin were the major compounds. In addition, this extract was microencapsulated by spray drying, which provided a protection feature of their antioxidant potential. Oregano extracts are rich in flavonoids and the microcapsules present promising results for future research.
Diabetes mellitus (DM) is a disease that affects over 537 million people worldwide and results in 6.7 million deaths annually. Conventional treatment of this disease focuses on lifestyle changes and drug administration. However, very few people can adhere to a healthier lifestyle, and drugs are difficult to access, especially in low- and middle-income countries. An alternative as an adjuvant to the treatment of DM is the phenolic compounds from plants with reported anti-diabetic effects. However, the bioavailability of these compounds is very low since they are affected by the gastrointestinal tract and xenobiotic metabolism. To improve the availability of these compounds, an emerging technology such as encapsulation is being used since it has been reported that the encapsulation of phenolic compounds improves both their bioaccessibility and bioavailability, as well as their bioactivity. In this review, we will focus on compiling the most up-to-date information on the different encapsulation processes of phenolic compounds and the antidiabetic effect of encapsulated phenolic compounds using the databases PubMed, Scopus, Web of Science, and Google Scholar. We will discuss the mechanisms, pathways, and receptors involved in the modulation of DM, especially those related to inflammation, oxidative stress, and insulin resistance.
Diabetes mellitus (DM) is a disease that affects over 537 million people worldwide and results in 6.7 million deaths annually. Conventional treatment of this disease focuses on lifestyle changes and drug administration. However, very few people can adhere to a healthier lifestyle, and drugs are difficult to access, especially in low- and middle-income countries. An alternative as an adjuvant to the treatment of DM is the phenolic compounds from plants with reported anti-diabetic effects. However, the bioavailability of these compounds is very low since they are affected by the gastrointestinal tract and xenobiotic metabolism. To improve the availability of these compounds, an emerging technology such as encapsulation is being used since it has been reported that the encapsulation of phenolic compounds improves both their bioaccessibility and bioavailability, as well as their bioactivity. In this review, we will focus on compiling the most up-to-date information on the different encapsulation processes of phenolic compounds and the antidiabetic effect of encapsulated phenolic compounds using the databases PubMed, Scopus, Web of Science, and Google Scholar. We will discuss the mechanisms, pathways, and receptors involved in the modulation of DM, especially those related to inflammation, oxidative stress, and insulin resistance.